These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28450156)

  • 1. microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression.
    Gu DN; Jiang MJ; Mei Z; Dai JJ; Dai CY; Fang C; Huang Q; Tian L
    Cancer Lett; 2017 Aug; 400():69-78. PubMed ID: 28450156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
    Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
    Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETS-1: A potential target of glycolysis for metabolic therapy by regulating glucose metabolism in pancreatic cancer.
    Zhang X; Wu D; Aldarouish M; Yin X; Li C; Wang C
    Int J Oncol; 2017 Jan; 50(1):232-240. PubMed ID: 27878249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
    Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
    Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
    Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
    Guo H; Nan Y; Zhen Y; Zhang Y; Guo L; Yu K; Huang Q; Zhong Y
    Tumour Biol; 2016 Oct; 37(10):13751-13761. PubMed ID: 27476171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
    Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
    J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.
    Zhang P; Tang WM; Zhang H; Li YQ; Peng Y; Wang J; Liu GN; Huang XT; Zhao JJ; Li G; Li AM; Bai Y; Chen Y; Ren YX; Li GX; Wang YD; Liu SD; Wang JD
    Br J Cancer; 2017 Aug; 117(4):525-534. PubMed ID: 28632723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
    Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
    Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting miR-21 for the therapy of pancreatic cancer.
    Sicard F; Gayral M; Lulka H; Buscail L; Cordelier P
    Mol Ther; 2013 May; 21(5):986-94. PubMed ID: 23481326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling.
    Xie G; Sun L; Li Y; Chen B; Wang C
    Cancer Med; 2021 Jan; 10(1):325-336. PubMed ID: 33231372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma.
    Chen W; Huang F; Huang J; Li Y; Peng J; Zhuang Y; Huang X; Lu L; Zhu Z; Zhang S
    J Gene Med; 2021 Sep; 23(9):e3364. PubMed ID: 34010493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
    Shukla SK; Gunda V; Abrego J; Haridas D; Mishra A; Souchek J; Chaika NV; Yu F; Sasson AR; Lazenby AJ; Batra SK; Singh PK
    Oncotarget; 2015 Aug; 6(22):19118-31. PubMed ID: 26046375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.
    Zhang P; Guo Z; Hu R; He X; Jiao X; Zhu X
    Tumour Biol; 2015 Dec; 36(12):9693-701. PubMed ID: 26152285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras.
    Sung S; Choi J; Cheong H
    Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.
    Zhao Y; Zhao L; Ischenko I; Bao Q; Schwarz B; Nieß H; Wang Y; Renner A; Mysliwietz J; Jauch KW; Nelson PJ; Ellwart JW; Bruns CJ; Camaj P
    Target Oncol; 2015 Dec; 10(4):535-48. PubMed ID: 25639539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.